NAD+, or beta-nicotinamide adenine dinucleotide, is an oxidized dinucleotide coenzyme supplied in a 1000 mg lyophilized format for controlled redox-metabolism, mitochondrial, sirtuin, PARP, CD38, and nucleotide-metabolism research.
1000 mg lyophilized research compound
Oxidized nicotinamide adenine dinucleotide
Dinucleotide coenzyme, not a peptide
≥98% HPLC-verified purity
Third-party tested
Certificate of Analysis documentation available upon request
Store at 2°C – 8°C or below, desiccated and protected from light
For laboratory research only. Not intended for human or animal consumption, administration, medical treatment, veterinary use, diagnostic use, supplement use, cosmetic use, household use, or personal use.
NAD+, or beta-nicotinamide adenine dinucleotide, is the oxidized form of a naturally occurring dinucleotide coenzyme involved in cellular metabolism.
NAD+ participates in reduction and oxidation reactions through the NAD+/NADH redox pair. These reactions play a role in glycolysis, the tricarboxylic-acid cycle, fatty-acid metabolism, mitochondrial respiration, and other biochemical processes involved in electron transfer.
Beyond its role as a coenzyme, NAD+ also serves as a substrate for several enzyme families. Published research has examined NAD+-dependent sirtuin activity, PARP-mediated ADP-ribosylation, CD38-associated NAD metabolism, DNA-damage responses, mitochondrial function, nucleotide metabolism, and cellular stress signalling.
Extracellular NAD+ may behave differently across experimental systems. Factors such as cellular uptake, extracellular degradation, enzyme expression, culture-medium composition, concentration, and exposure duration can all influence observed responses.
BioVault Labs supplies NAD+ in a 1000 mg lyophilized research format with ≥98% HPLC-verified purity. The product is third-party tested, with available product documentation provided upon request.
